| Asset | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 |
|---|---|---|---|---|---|---|
| Equity | 97.08% | 95.05% | 94.45% | 95.25% | 98.67% | 98.21% |
| Debt | 0.02% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Others (incl. cash) | 2.90% | 4.95% | 5.54% | 4.74% | 1.32% | 1.79% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 6,00,000 | 119.43 | 8.71% | 0.17%↑ |
| Divis Laboratories Ltd. | Healthcare | 94,707 | 76.3 | 5.57% | 0.83%↑ |
| Ajanta Pharma Ltd. | Healthcare | 1,90,000 | 65.84 | 4.80% | -0.27%↓ |
| Caplin Point Laboratories Ltd. | Healthcare | 2,15,000 | 54.11 | 3.95% | -0.07%↓ |
| Lupin Ltd. | Healthcare | 2,03,834 | 49.23 | 3.59% | -0.18%↓ |
| Gland Pharma Ltd. | Healthcare | 1,95,000 | 48.81 | 3.56% | -0.55%↓ |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 53,000 | 47.47 | 3.46% | -0.06%↓ |
| Dr. Reddys Laboratories Ltd. | Healthcare | 3,70,000 | 42.48 | 3.10% | 0.09%↑ |
| Alkem Laboratories Ltd. | Healthcare | 73,830 | 42.46 | 3.10% | -0.05%↓ |
| Global Health Ltd. | Healthcare | 2,74,290 | 38.55 | 2.81% | 0.20%↑ |
| Max Healthcare Institute Ltd. | Healthcare | 3,44,969 | 37.89 | 2.76% | -0.21%↓ |
| Ipca Laboratories Ltd. | Healthcare | 2,10,026 | 36.71 | 2.68% | -0.05%↓ |
| Fortis Healthcare Ltd. | Healthcare | 3,75,000 | 35.44 | 2.58% | -0.34%↓ |
| Anthem Biosciences Ltd. | Healthcare | 4,23,347 | 34.26 | 2.50% | 0.00%↑ |
| Procter & Gamble Health Ltd. | Healthcare | 50,000 | 33.02 | 2.41% | -0.01%↓ |
| Rainbow Childrens Medicare Ltd. | Healthcare | 2,10,000 | 32.03 | 2.34% | 0.28%↑ |
| Sai Life Sciences Ltd. | Healthcare | 2,29,623 | 30.2 | 2.20% | 0.04%↑ |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 9,03,130 | 29.94 | 2.18% | - |
| Cohance Lifesciences Ltd. | Healthcare | 7,00,000 | 29.75 | 2.17% | -0.27%↓ |
| Marksans Pharma Ltd. | Healthcare | 11,50,000 | 29.71 | 2.17% | 0.08%↑ |
| Sector | 31 Jul 2026 | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 |
|---|---|---|---|---|---|---|
| Healthcare | 96.35% | 94.27% | 93.67% | 94.28% | 97.83% | 97.37% |
| Services | 0.73% | 0.78% | 0.78% | 0.97% | 0.84% | 0.84% |
31.0 / 100
Weighted average Value score is 31.0. This indicates that portfolio is relatively reasonably valued using composite of value measures.
71.0 / 100
Weighted average Price Momentum score is 71.0. This indicates that portfolio has average momentum using composite of momentum measures.
84.9 / 100
Weighted average Quality score is 84.9. This indicates that portfolio has high quality using composite of quality measures.
72.7 / 100
Weighted average QVM score is 72.7. This indicates that portfolio has average QVM score and hence a neutral stance is warranted.
